BioAge Labs, Inc. Common Stock
XNAS:BIOA
8.81
$9.95 - 100.00
$7.88 - 100.00
$8.9
$9.36
$9.36
$9.49
20.37
2.88
207781
229910.4
22504737.3
Chart
TendieTensor AI Analysis
Company
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
Fundamentals
64
-4.220000
1.153810
-0.56
100
BBG00HBTB0M9
BBG00HBTB0N8
35.85M
35.86M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own BIOA. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.